Shanti K. Samuel

1.2k total citations
19 papers, 1.0k citations indexed

About

Shanti K. Samuel is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Shanti K. Samuel has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Shanti K. Samuel's work include RNA Research and Splicing (6 papers), Genomics and Chromatin Dynamics (6 papers) and Nuclear Structure and Function (5 papers). Shanti K. Samuel is often cited by papers focused on RNA Research and Splicing (6 papers), Genomics and Chromatin Dynamics (6 papers) and Nuclear Structure and Function (5 papers). Shanti K. Samuel collaborates with scholars based in Canada, United States and France. Shanti K. Samuel's co-authors include James Davie, Virginia A. Spencer, Harry B. Greenberg, Robert A. R. Hurta, James R. Wright, Eva A. Turley, Steffi Oesterreich, Chao Wang, Arnold H. Greenberg and Baihua Yang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Shanti K. Samuel

19 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanti K. Samuel Canada 18 751 319 164 124 113 19 1.0k
Dvorah Ish‐Shalom Israel 10 794 1.1× 437 1.4× 296 1.8× 238 1.9× 167 1.5× 12 1.2k
Yamina Hamma‐Kourbali France 17 600 0.8× 192 0.6× 215 1.3× 108 0.9× 186 1.6× 25 966
Xavier Canron France 11 614 0.8× 117 0.4× 285 1.7× 102 0.8× 136 1.2× 12 879
Carl M. Svahn United States 10 864 1.2× 689 2.2× 79 0.5× 123 1.0× 146 1.3× 11 1.2k
Catherine F. Welsh United States 14 470 0.6× 261 0.8× 306 1.9× 87 0.7× 149 1.3× 24 858
M. Mareel Belgium 11 894 1.2× 260 0.8× 363 2.2× 238 1.9× 151 1.3× 24 1.3k
Lydia Armstrong United States 12 600 0.8× 156 0.5× 299 1.8× 237 1.9× 119 1.1× 19 872
Susann Schenk United States 8 367 0.5× 191 0.6× 149 0.9× 270 2.2× 203 1.8× 8 791
Tracey J. Brown Australia 14 553 0.7× 492 1.5× 184 1.1× 57 0.5× 98 0.9× 21 830
Angelo Vacca Italy 8 445 0.6× 104 0.3× 144 0.9× 115 0.9× 133 1.2× 9 758

Countries citing papers authored by Shanti K. Samuel

Since Specialization
Citations

This map shows the geographic impact of Shanti K. Samuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanti K. Samuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanti K. Samuel more than expected).

Fields of papers citing papers by Shanti K. Samuel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanti K. Samuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanti K. Samuel. The network helps show where Shanti K. Samuel may publish in the future.

Co-authorship network of co-authors of Shanti K. Samuel

This figure shows the co-authorship network connecting the top 25 collaborators of Shanti K. Samuel. A scholar is included among the top collaborators of Shanti K. Samuel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanti K. Samuel. Shanti K. Samuel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Samuel, Shanti K., et al.. (2003). The mechanism of action of docetaxel (Taxotere®) in xenograft models is not limited to bcl-2 phosphorylation. Investigational New Drugs. 21(3). 259–268. 46 indexed citations
3.
Matragoon, S., et al.. (2002). MAP kinase and beta-catenin signaling in HGF induced RPE migration.. PubMed. 8. 483–93. 40 indexed citations
4.
Spencer, Virginia A., Shanti K. Samuel, & James Davie. (2001). Altered profiles in nuclear matrix proteins associated with DNA in situ during progression of breast cancer cells.. PubMed. 61(4). 1362–6. 25 indexed citations
5.
Spencer, Virginia A., Shanti K. Samuel, & James Davie. (2000). Nuclear matrix proteins associated with DNA in situ in hormone-dependent and hormone-independent human breast cancer cell lines.. PubMed. 60(2). 288–92. 31 indexed citations
6.
Davie, James, Shanti K. Samuel, Virginia A. Spencer, et al.. (1999). Organization of chromatin in cancer cells: role of signalling pathways. Biochemistry and Cell Biology. 77(4). 265–275. 34 indexed citations
7.
Sun, Jianmin, Hou Yu Chen, Mariko Moniwa, Shanti K. Samuel, & James Davie. (1999). Purification and Characterization of Chicken Erythrocyte Histone Deacetylase 1. Biochemistry. 38(18). 5939–5947. 18 indexed citations
8.
Davie, James, Shanti K. Samuel, Virginia A. Spencer, et al.. (1999). Organization of chromatin in cancer cells: role of signalling pathways. Biochemistry and Cell Biology. 77(4). 265–275. 28 indexed citations
9.
Spencer, Virginia A., Amanda S. Coutts, Shanti K. Samuel, Leigh C. Murphy, & James Davie. (1998). Estrogen Regulates the Association of Intermediate Filament Proteins with Nuclear DNA in Human Breast Cancer Cells. Journal of Biological Chemistry. 273(44). 29093–29097. 37 indexed citations
10.
Holth, Laurel T., Deborah Chadee, Virginia A. Spencer, et al.. (1998). Chromatin, nuclear matrix and the cytoskeleton: role of cell structure in neoplastic transformation (review).. International Journal of Oncology. 13(4). 827–37. 31 indexed citations
11.
Samuel, Shanti K., Virginia A. Spencer, Jian-Min Sun, et al.. (1998). In situ cross-linking by cisplatin of nuclear matrix-bound transcription factors to nuclear DNA of human breast cancer cells.. PubMed. 58(14). 3004–8. 57 indexed citations
12.
Oesterreich, Steffi, et al.. (1997). Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. Journal of Cellular Biochemistry. 67(2). 275–286. 5 indexed citations
13.
Samuel, Shanti K., et al.. (1997). Altered nuclear matrix protein profiles in oncogene-transformed mouse fibroblasts exhibiting high metastatic potential.. PubMed. 57(1). 147–51. 24 indexed citations
14.
Oesterreich, Steffi, et al.. (1997). Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. Journal of Cellular Biochemistry. 67(2). 275–286. 87 indexed citations
15.
Samuel, Shanti K., et al.. (1997). Nuclear matrix proteins in well and poorly differentiated human breast cancer cell lines. Journal of Cellular Biochemistry. 66(1). 9–15. 24 indexed citations
16.
Hall, Christine, Baihua Yang, Shiwen Zhang, et al.. (1995). Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell. 82(1). 19–28. 251 indexed citations
17.
Samuel, Shanti K., Robert A. R. Hurta, M.A. Spearman, et al.. (1993). TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.. The Journal of Cell Biology. 123(3). 749–758. 108 indexed citations
18.
Samuel, Shanti K., Robert A. R. Hurta, Paturu Kondaiah, et al.. (1992). Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225).. The EMBO Journal. 11(4). 1599–1605. 105 indexed citations
19.
Hurta, Robert A. R., Shanti K. Samuel, Harry B. Greenberg, & James R. Wright. (1991). Early induction of ribonucleotide reductase gene expression by transforming growth factor beta 1 in malignant H-ras transformed cell lines.. Journal of Biological Chemistry. 266(35). 24097–24100. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dvorah Ish‐Shalom Breakdown of academic impact, for papers by Yamina Hamma‐Kourbali Breakdown of academic impact, for papers by Xavier Canron Breakdown of academic impact, for papers by Carl M. Svahn Breakdown of academic impact, for papers by Catherine F. Welsh Breakdown of academic impact, for papers by M. Mareel Breakdown of academic impact, for papers by Lydia Armstrong Breakdown of academic impact, for papers by Susann Schenk Breakdown of academic impact, for papers by Tracey J. Brown Breakdown of academic impact, for papers by Angelo Vacca
Rankless by CCL
2026